Susceptibility factors and non-invasive biomarkers for liver steatosis induced by valproate in pediatric epileptic patients.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
INSTITUTO DE SALUD CARLOS III
RAMIRO JOVER ATIENZA
Resultados del Ensayo Clínico
Cluster-Partial Least Squares (c-PLS) regression analysis: Application to miRNA and metabolomic data
Kuligowski, J; (...); Quintás, G
Article. 10.1016/j.aca.2023.342052. 2024
Idiosyncratic Drug-Induced Liver Injury and Amoxicillin-Clavulanate: Spotlight on Gut Microbiota, Fecal Metabolome and Bile Acid Profile in Patients
Román-Sagüillo, S; (...); Sánchez-Campos, S
Article. 10.3390/ijms25136863. 2024
The Development of a Non-Invasive Screening Method Based on Serum microRNAs to Quantify the Percentage of Liver Steatosis
Soluyanova, P; (...); Jover, R
Article. 10.3390/biom14111423. 2024
Cita
Susceptibility factors and non-invasive biomarkers for liver steatosis induced by valproate in pediatric epileptic patients. (PI20/00690). INSTITUTO DE SALUD CARLOS III; JOVER. 2021-2024. IP:RAMIRO JOVER ATIENZA.
Portal de investigación